1. Nikola Stefanović, Katarina Danković, Radmila Veličković-Radovanović, Marija Vukelić-Nikolić, Maša Jović, Stevan Vujić, Vladana Stojiljković, Branka Mitić, Tatjana Cvetković. Urinary microRNA expression and tacrolimus pharmacokinetic variability in kidney transplant recipients: a cross-sectional study. Clin Drug Investig 2026; 46(5):517-530. IF: 3.1 (M22)
2. Sonja Dakić, Zoran Perišić, Svetlana Apostolović, Tomislav Kostić, Goran Koraćević, Tatjana Jevtović, Boris Đinđić, Nikola Stefanović, Danijela Đorđević-Radojković, Bojan Maričić, Dragana Stanojević, Maša Jović, Jelena Perišić, Tamara Filipović. CYP3A4, CYP3A5, and CYP4F2 Polymorphisms and Bleeding Risk in Ticagrelor-Based Dual Antiplatelet Therapy. Medicina (Lithuania) 2026; 62(6):1202. IF: 2.9 (M21)
3. Ivan R. Pavlović, Nikola Stefanović, Nikola Despenić, Dragana R. Pavlović, Maša Jović, Radmila Velicković-Radovanović, Branka Mitić, Tatjana P. Cvetković. Numerical modeling and prediction of late estimated glomerular filtration rate in kidney transplant recipients based on machine learning models and the Monte Carlo simulation method. Biomed Tech 2026; 71(2):129-135. IF: 1.3 (M23)
4. Nikola Stefanović, Maša Jović, Katarina Danković, Ivana Damnjanović, Branislav Apostolović, Branka Mitić, Radmila Veličković-Radovanović. Evaluating the relationship between the number of drug interactions and tacrolimus exposure in the first year post-kidney transplantation: a comparative study of interaction databases. Farmacia 2025; 73(4): 882-892. IF: 1.6 (M23)
5. Valentina N. Nikolić, Milan Stefanović, Dejan Mitić, Slavica Sunarić, Maša Jović, Hristina Trajković, Sanja Stanković, Aleksandra Ignjatović, Dragana Stokanović. Factors contributing to variability in metformin concentration in polycystic ovary syndrome. Croat Med J 2024; 65(2):138-145. IF: 2.3 (M21)
6. Katarina Danković, Nikola Stefanović, Tatjana Cvetković, Stevan Vujić, Maša Jović, Branka Mitić, Radmila Veličković-Radovanović. Potential influence of interleukin-6 -174G/C gene polymorphism on kidney graft function and tacrolimus dose requirements: five-year follow-up. Xenobiotica 2024;54(10):855-863. IF: 1.2 (M23)
7. Sanja Stanković,Nikola Stefanović, Maša Jović, Radmila Veličković-Radovanović. Comparative analysis of potential drug-drug interactions at the level of public pharmacy. Acta Fac Med Naiss 2024;41(3): 320-333. IF: 0.3 (M22)
1. Maša Jović, Radmila Veličković-Radovanović, Miodrag Cekić, Stevan Vujić, Nikola Krstić, Aleksandra Catić-Đorđević, Nikola Stefanović. Impact of ABCG2 421 C>A and SLCO1B1 521T>C gene polymorphism on the control of lipid status in patients on atorvastatin and rosuvastatin treatment. Acta Medica Medianae 2025; 64(3): 24-33. (M52)